Safe and Effective Discontinuation of High-Risk Medications (Clinical Track) [7132] | |||||||||||||||||||||
Date: Friday, March 9, 2018 Time: 8:50 AM - 9:50 AM Location: Greater Columbus Convention Center Room: Short North Ballroom A Speakers: Mark Pew, Senior Vice President, PRIUM Session Type: Educational Session Description: An inappropriate polypharmacy regimen, often the result of cascading negative side effects from an initial opioid, creates a complicated situation for discontiuation. In what sequence should you taperĀ drugs/classifications? What are the pros and cons of medication assisted treatment (MAT) vs. non-MAT tapering? How do you properly address psychosocialspiritual issues and co-morbidities? Proper tapering is complex and individualized. This sessionĀ helps define best practices. Learning Objectives: Explain the genesis and scope of the opioid epidemic Define appropriate and inappropriate uses of prescription painkillers Describe the biopsychosocialspiritual treatment model and implications to choices Summarize tapering options and best practices
File & Handouts: File 1 |
|||||||||||||||||||||
Search sessions by day, speaker, keyword, session type, or display all sessions. |
|||||||||||||||||||||
|